- Enable Injections, Inc. ("Enable"), a leader in wearable drug delivery technology, today announced an expanded partnership with Roche.
- The collaboration leverages Enable's expertise in the enFuse® platform to accelerate the development and commercialization of innovative treatment options.
EnFuse Technology: Revolutionizing Drug Delivery
The enFuse platform is a groundbreaking wearable device designed for:
Subcutaneous Delivery of Large Volumes: Unlike traditional methods,
Read More
Roche
HLTH22 Day 3 News Summary
DispatchHealth Raises $330M for Hospital-at-Home Care
DispatchHealth, a provider of in-home medical care raises $330M led by Optum Ventures with support from current investors such as Humana (NYSE: HUM), Oak HC/FT, Echo Health Ventures and Questa Capital. New investors included Adams Street Partners, the Olayan Group, Silicon Valley Bank, Pegasus Tech Ventures and Blue Shield of California. Patients and their care partners can request DispatchHealth medical care via phone, mobile app, or
Read More
Vivalink Integrates with Garmin, Other Wearables to Address RPM Interoperability
What You Should Know:
- Vivalink is addressing these RPM interoperability challenges by announcing today that leading wearables and medical-grade devices are integrating with the company’s Biometrics Data Platform.
- Now, leading pulse oximeters, blood glucose monitors and sleep monitors by companies like Garmin and Roche are available alongside the Platform to accelerate development and deployment of novel healthcare applications and research.
Why It Matters
Integration and
Read More
KLAS: State of Digital Pathology Among Early Adopters in 2022
What You Should Know:
- In anticipation, many technology vendors are vying for a foothold in the US, leading to a highly varied landscape. In partnership with the Digital Pathology Association (DPA), KLAS surveyed 55 provider organizations (including hospitals, health systems, academic health centers, and reference labs) to assess the state of digital pathology among pioneers in the US and determine which vendors are gaining traction.
- 33 of the interviewed organizations are live with
Read More
Lyfegen Raises $8M for Value-Based Contracting for High-Cost Drugs
What You Should Know:
- Lyfegen, a global health tech SaaS company driving the world’s transition from volume to value-based healthcare for high-cost drugs raises $8M in Series A financing round led by aMoon, with additional participation from APEX Ventures and others.
- Lyfegen’s value-based contracting software is used by healthcare payers and leading pharma companies, including Novartis, Roche, MSD, Bristol Myers Squibb (BMS) and Johnson & Johnson.
Value-Based
Read More
What is the Potential for Digital Twins in Healthcare?
Digital twins are virtual representations of an object or system that spans its lifecycle, is updated from real-time data, and use simulation, machine learning and reasoning to help decision-making (IBM). In most cases, this helps data scientists understand how products are operating in production environments and anticipate how they may behave overtime. But what happens when a digital twin is that of a human being?
By using digital twins to model a person, you can use technologies like
Read More
Glooko Launches Diabetes Medical Education Academy in Ireland
What You Should Know:
- Glooko announced, in partnership with the Diabetes Technology Network (DTN)/Association of British Clinical Diabetologists (ABCD), the expansion into Ireland of Academy, the company’s online medical education program for clinicians who treat people with diabetes.
- Originally inspired after discussions with the National Health Service England (NHSE) as part of its effort to ensure all healthcare professionals learn uniformly about technology, the program will help
Read More
Precision Medicine Startup Prenosis Raises $20M for Acute Care Solutions, Starting with Sepsis
What You Should Know:
- Prenosis, Inc., a precision medicine company, announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes. This investment brings total funding in the company to over $20 million, including partnerships with Foxconn, Roche Diagnostics, the Defense Threat Reduction Agency, and others.
- Precision medicine company will use the funding to
Read More
BrightInsight & UCB Partner to Build Digital Care Solutions for Rare Diseases
What You Should Know:
- BrightInsight, provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced a partnership with global biopharma, UC to build digital care solutions for rare diseases.
- BrightInsight will build and bring to market a digital disease management solution to support patients with Myasthenia Gravis (MG), a rare autoimmune disease that disrupts how nerves communicate with muscles, affecting more than 700,000 people
Read More
HLTH21: Roche, Ibex Medical Partner to Develop AI-Powered Digital Pathology Apps
What You Should Know:
- Ibex Medical Analytics, the pioneer in AI-based cancer diagnostics, today announced that it has signed a deal with Roche, the world’s largest biotech company and global pioneer in pharmaceuticals and diagnostics. Ibex will be integrating its Galen™ platform into Roche’s uPath enterprise cloud software in order to help pathologists to enable pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology,
Read More
